经肱动脉路径冠状动脉介入治疗患者组合式压迫止血器应用效果观察
作者:
作者单位:

作者简介:

女,本科,主管护师

通讯作者:

基金项目:

华中科技大学同济医学院附属同济医院院基金项目(2019YJJD09)


Application effect of combined compression hemostasis device in patients undergoing percutaneous coronary intervention via brachial artery approach
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨组合式压迫止血器在经肱动脉路径行冠脉动脉介入治疗压迫止血的效果。方法将经肱动脉路径行冠状动脉介入治疗患者60例分成两组各30例。对照组采用3M弹力绷带加压包扎的常规止血方法,观察组采用组合式压迫止血器压迫止血。比较两组压迫止血即刻,术后2 h、4 h、6 h出血发生率、局部肿胀程度及疼痛评分;压迫24 h局部压力性损伤发生率。结果观察组不同时段局部肿胀程度及疼痛评分显著低于对照组,总出血发生率和压力性损伤发生率显著低于对照组(均P<0.05)。结论组合式肱动脉止血器应用于经肱动脉路径行冠状动脉介入治疗压迫止血效果良好,操作安全且能减轻患者疼痛,预防压力性损伤发生。

    Abstract:

    Objective To explore the effect of combined compression hemostasis device in promoting vascular hemostasis following percutaneous coronary intervention (PCI) via the brachial artery approach. MethodsSixty patients who underwent PCI using the brachial approach were divided into two groups, with 30 patients in each group. The control group was given conventional compression using 3M elastic bandage, while the intervention group used the combined compression hemostasis device. Incidence of bleeding, local swelling degree and pain were compared between the two groups immediately and at 2, 4, and 6 hours after the procedure. The occurrence of pressure injury at the compression site was also observed for 24 hours. ResultsCompared with the control group, the intervention group had significantly milder local swelling and pain at different time points, and also significantly lower incidence of bleeding and pressure injury (all P<0.05). ConclusionThe combined compression hemostasis device achieved better vascular hemostasis and was safe for operation, resulting in significant reductions in pain and pressure injuries.

    参考文献
    相似文献
    引证文献
引用本文

郑锐,辜莹,何细飞,周舸,陶敏.经肱动脉路径冠状动脉介入治疗患者组合式压迫止血器应用效果观察[J].护理学杂志,2023,28(18):55-58

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2023-03-02
  • 最后修改日期:2023-05-05
  • 录用日期:
  • 在线发布日期: 2023-12-29